Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | |
| Sales | 8 | 0 | 0 |
| Cost of Goods | 5 | N/A | N/A |
| Gross Profit | 3 | N/A | N/A |
| Operating Expenses | 4,728 | 3,001 | 1,166 |
| Operating Income | -4,725 | -3,001 | -1,166 |
| Interest Expense | 5,228 | 334 | 26 |
| Pre-tax Income | -9,953 | -3,335 | -1,192 |
| Net Income Continuous | -9,953 | -3,335 | -1,192 |
| Net Income | $-9,953 | $-3,335 | $-1,192 |
| EPS Basic Total Ops | -3.90 | -1.95 | -0.54 |
| EPS Basic Continuous Ops | -3.90 | -1.95 | N/A |
| EPS Diluted Total Ops | -3.90 | -1.95 | -0.54 |
| EPS Diluted Continuous Ops | -3.90 | -1.95 | N/A |
| EBITDA(a) | $-4,685 | $-2,978 | $-1,166 |